Growth inhibitory effect of interferon-β is associated with the induction of cyclin-dependent kinase inhibitor p27(Kip1) in a human gastric carcinoma cell line

Cell Growth and Differentiation

Volumn 8, Issue 1, 1997, Pages 47-52

  Kuniyasu, H ^a   Yasui, W ^a   Kitahara, K ^a   Naka, K ^a   Yokozaki, H ^a   Akama, Y ^a   Hamamoto, T ^a   Tahara, H ^a   Tahara, E ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; STOMACH CARCINOMA;

ADENOCARCINOMA; APOPTOSIS; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; HUMANS; INTERFERON-BETA; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RETINOBLASTOMA PROTEIN; STOMACH NEOPLASMS; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0031014017     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Borden, E. C. Interferon-expanding therapeutic roles. N. Engl. J. Med., 326: 1491-1493, 1992.
2. Gutch, M. J., Daly, C., and Reich, N. C. Tyrosine phosphorylation is required for activation of an α-interferon-stimulated transcription factor. Proc. Natl. Acad. Sci. USA, 89: 11411-11415, 1992.
3. Schindler, C., Shuai, K., Prezioso, V. R., and Darnell, J. E. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science (Washington DC), 257: 809-813, 1992.
4. Fu, X. Y., and Zhang, J. J. Transcriptional factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promotor. Cell, 74: 1135-1145, 1993.
5. Taniguchi, T., Harada, H., and Lamphier, M. Regulation of the interferon system and cell growth by the IRF transcription factors. J. Cancer Res. Clin. Oncol., 121: 516-520, 1995.
6. Harada, H., Takahashi, E., Itoh, S., Harada, K., Hori, T. A., and Taniguchi, T. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol. Cell. Biol., 14: 1500-1509, 1994.
7. Otto, A. M. Combination of interferon with platinum complexes: synergistic and antagonistic effects on growth inhibition of MCF-7 and MDAMB231 breast cancer cells. J. Cancer Res. Clin. Oncol., 120: 286-292, 1994.
8. Schiller, J. H., and Bittner, G. Antiproliferative effects of tumor necrosis factor, γ-interferon, and 5-fluorouracil on human colorectal carcinoma cell lines. Int. J. Cancer, 46: 61-66, 1990.
9. Gohji, K., Murao, S., Maeda, S., Sugiyama, T., and Kamidono, S. Enhanced inhibition of colony formation of human renal cell carcinoma in soft agar by the combination of α-difluoromethylornithine and recombinant γ-interferon. Cancer Res., 46: 6264-6268, 1986.
10. Novelli, F., Di Pierro, F., Franciadi Celle, P., Bertini, S., Affaticati, P., Garotta, G., and Forni, G. Environmental signals influencing expression of the IFN-γ receptor on human T cells control whether IFN-γ promotes proliferation or apoptosis. J. Immunol., 152: 496-504, 1994.
11. Rodriguez Villanueva, J., and McDonnell, T. J. Induction of apoptotic cell death in non-melanoma skin cancer by interferon-α. Int. J. Cancer, 61: 110-114, 1995.
12. Kumar, R., and Mendelsohn, J. Role of 2′-5′-oligoadenylate synthetase in γ-interferon-mediated growth inhibition of A431 cells. Cancer Res., 49: 5180-5184, 1989.
13. Kumar, R., and Atlas, I. Interferon-α induces the expression of retinoblastoma gene product in human Burkitt's lymphoma Daudi cells: role in growth regulation. Proc. Natl. Acad. Sci. USA, 89: 6599-6603, 1992.
14. Resnitzky, D., Tiefenbrun, N., Berissi, H., and Kimchi, A. Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc. Natl. Acad. Sci. USA, 89: 402-406, 1992.
15. 1 cyclins. Cell, 73: 1059-1065, 1993.
16. EI-Deiry, W. S., Tokino, T., Velcuscu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
17. 1 cyclin-dependent kinase. Cell, 75: 805-816, 1993.
18. Noda, A., Ning, Y., Veneble, S. F., Pereira Smith, O. M., and Smith, J. R. Cloning of senescent cell-derived inhibitor of DNA synthesis using an expression screen. Exp. Cell Res., 211: 90-98, 1994.
19. 1 cyclin-cdk protein kinase activity, is related to p21. Cell, 78: 67-74, 1994.
20. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59-66, 1994.
21. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
22. Hannon, G. J., and Beach, D. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature (Lond.), 371: 257-260, 1994.
23. Zhang, K., and Kumar, R. Interferon-α inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells. Biochem. Biophys. Res. Commun., 200: 522-528, 1994.
24. Barlat, I., Henglein, B., Plet, A., Lamb, N., Fernandez, A., McKenzie, F., Pouyssegur, J., Vie, A., and Blanchard, J. M. TGF-β1 and cAMP attenuate cyclin A gene transcription via a cAMP-responsive element through independent pathways. Oncogene, 11: 1309-1318, 1995.
25. Novick, D., Cohoen, B., and Rubinstein, M. The human Interferon α/β receptor: characterization and molecular cloning. Cell, 77: 391-400, 1994.
26. Cohen, B., Novick, D., Barak, S., and Rubinstein, M.: Ligand-induced association of the type I interferon receptor components. Mol. Cell. Biol., 15: 4208-4214, 1995.
27. Domanski, P., Witte, M., Kellum, M., Rubinstein, M., Hackett, R., Pitha, P., and Colamonici, O. R. Cloning and expression of a long form of the β subunit of the interferon-α/β receptor that is required for signaling. J. Biol. Chem., 270: 21606-21611, 1995.
28. Silvennoinen, O., Schindler, C., Schlessinger, J., and Levy, D. E. Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation. Science (Washington DC), 261: 1736-1739, 1993.
29. Sadowski, H. B., Shuai, K., Darnell, J. E., Jr., and Gilman, M. Z. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science (Washington DC), 261: 1739-1744, 1993.
30. Muller, M., Briscoe, J., Laxton, C., Guschin, D., and Kerr, I. M. The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction. Nature (Lond.), 366: 129-135, 1993.
31. Witthuhn, B. A., Silvennoinen, O., Miura, O., Lai, K. S., Cwik, C., Liu, E. T., and Ihle, J. N. Involvement of the Jak-3 Janus kinase in signaling by interleukin 2 and 4 in lymphoid and myeloid cells. Nature (Lond.), 370: 153-157, 1994.
32. Darnell, J. E., Jr., Kerr, I. M., and Stark, G. R. Jak-STAT pathway and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (Washington DC), 264: 1415-1421, 1994.
33. Xu, B., Grander, D., Sangfelt, O., and Einhorn, S. Primary leukemia cells resistant to α-interferon in vitro are defective in the activation of the DNA-binding factor interferon-stimulated gene factor 3. Blood, 84: 1942-1949, 1994.
34. Hunter, T., and Pines, J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
35. WAF1/CIP1 mediated by STAT1. Science (Washington DC), 272: 719-722, 1996.
36. 1 cyclindependent kinases. Genes & Dev., 9: 1149-1163, 1995.
37. MTS1 gene status in human esophageal carcinoma cell lines. J. Exp. Therap, Oncol., 1: 7-12, 1996.
38. Reynisdottir, I., Polyak, K., lavarone, A., and Massague, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev., 9: 1831-1845, 1995.
39. Bates, S., Bonetta, L., MacAllan, D., Parry, D., Holder, A., Dickson, C., and Peters, G. CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene, 9: 71-79, 1994.
40. Lee, S. B., and Esteban, M. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology, 199: 491-496, 1994.
41. Brugarolus, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., and Hannon, G. J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (Lond.), 377: 552-557, 1995.
42. 1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
43. Sdi1/CIP1/WAF1. EMBO J., 14: 555-563, 1995.
44. Ochiai, A., Yasui, W., and Tahara, E. Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn. J. Cancer Res., 76: 1064-1071, 1985.
45. Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1984.
46. Kuniyasu, H., Yasui, W., Akama, Y., Akagi, M., Tohodo, H., Ji, Z-Q., Kitadai, Y., Yokozaki, H., and Tahara, E. Expression of cripto in human gastric carcinomas: an association with tumor stage and prognosis. J. Exp. Clin. Cancer Res., 13: 151-157, 1994.
47. cdc2 and its kinase activity in human gastric and colonic carcinomas. Int. J. Cancer, 53: 36-41, 1993.
48. Akagi, M., Yasui, W., Akama, Y., Yokozaki, H., Tahara, H., Haruma, K., Kajiyama, G., and Tahara, E. Inhibition of cell growth by transforming growth factor β1 is associated with p53-independent induction of p21 in gastric carcinoma cells. Jpn. J. Cancer Res, 87: 377-384, 1996.
49. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.